Dr. Ara H. Rostomian, MBA, MD, MPH

Dr. Rostomian practices at Panorama City Medical Center in Panorama City, California, part of Kaiser Permanente.

Dr. Rostomian's NPI, 1932580990, was assigned on June 16, 2015. Dr. Rostomian graduated from David Geffen School of Medicine at UCLA in 2014. Dr. Rostomian holds California license A145935.

Dr. Rostomian's primary practice is Panorama City Medical Center, at 13652 Cantara St, Panorama City, CA 91402 in Los Angeles County. The practice phone is (818) 375-2000.

Dr. Rostomian's primary practice is Panorama City Medical Center in Panorama City, California, part of Kaiser Permanente. Dr. Rostomian is also affiliated with Olive View-UCLA Medical Center. The medical group on file is Southern California Permanente Medical Group. Dmand AI also links Dr. Rostomian to 2 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rostomian practices, 2 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Rostomian's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Rostomian is board certified in cardiovascular disease by the American Board of Internal Medicine. Dr. Rostomian is licensed in California.

CMS data shows 118 Medicare services from Dr. Rostomian across 2 procedure codes in 2024, for 119 Medicare patients. Medicare paid $3,484 for them.

CMS counts 119 Medicare patients who saw Dr. Rostomian in 2024. The largest group is 65 to 74, with 59 patients. 67% of them have high blood pressure, and 63% have high cholesterol. 61% are also on Medicaid. Their average risk score is 2.25, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rostomian's median patient age at 63, with 61% women.

In 2024, Dr. Rostomian wrote 1,221 Medicare Part D claims for 296 patients. 81% of them were for generic drugs. CMS names the drug for 1,113 of them, across 22 drugs with 11 or more claims each, at $180,094 in total drug cost. In 2023, CMS named 432 claims across 13 drugs.

Dr. Rostomian accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Dr. Rostomian, published from 2011 to 2020. 2011 was the busiest year, with 2. Dr. Rostomian's most frequent co-authors are William Jagust, MD and Ray Zadegan, MD.

CMS Open Payments shows 2 general payments to Dr. Rostomian from 2 drug and device companies in 2023. Food and beverage make up the largest share, 53% of the total. Abbott Laboratories paid the most, $139.

Dr. Rostomian graduated from David Geffen School of Medicine at UCLA in 2014.

Dr. Rostomian is in network with 2 carriers, including Kaiser Permanente and CMS Medicare. EPO plans come from the most carriers, 1. Check the plan with the practice before a visit.